Ping An Biomedical announced a letter of intent to acquire three patents related to tumor cell medical technologies, including oncology diagnosis, cell detection, and biomarker technologies, for $2-2.5 million. This acquisition aims to build a core intellectual property portfolio supporting the company's long-term healthcare and biomedical R&D strategy. The patents will form the foundation for future development, collaboration, and commercialization in oncology and biotech sectors. The deal is subject to due diligence and final agreements, with no immediate revenue expected from the acquisition itself.
Ping An Biomedical's planned acquisition of tumor cell-related medical technology patents is presented here with Pluang's health sector market data as of Oct 23, 2026 00:41 WIB. Of 150 priced health-sector US stocks tradable on Pluang, 79 rose and 70 fell today. Notable movers include HRTX at USD 0.30 with a 1-day change of -11.22% and Pluang order activity showing 20% Sell / 80% Buy, TWST at USD 133.15 down 10.72% with 7% Sell / 93% Buy, and TXG at USD 68.47 down 9.42% with 0% Sell / 100% Buy. The most notable figure is TXG's 100% buy order activity on Pluang.
Share-ify introduced the S.A.F.E. Score™, an AI-powered forecasting engine designed to enhance supplier risk intelligence within its food safety and compliance solutions. This tool analyzes diverse data such as audit results, recall history, and insp...
EquipmentShare, a major U.S. construction equipment rental and technology provider, will announce its fiscal third quarter 2026 financial results after market close on November 9, 2026. The company will host a conference call for investors and analys...
Atlantic American Corporation received a Nasdaq Staff Delisting Determination due to missing its 2025 annual and 2026 quarterly SEC reports by the extended October 12 deadline. The company has since filed the 2025 annual report and is working to subm...
Randstad reported revenue and earnings that exceeded expectations, driven by improving business trends and key labor markets. This positive performance signals momentum in the employment services sector. RBC Capital maintained a 'Sector Perform' rati...
MSC Industrial Supply reported strong Q4 results with revenue rising 10.3% year-over-year to about $1.08 billion, surpassing estimates. Adjusted earnings per share increased to $1.45 from $1.09, also beating expectations. Full-year sales grew 6.4% to...
